Zobrazeno 1 - 10
of 177
pro vyhledávání: '"Yoshiyuki Takahashi"'
Autor:
Maho Sato, Tomohiro Morio, Hiromasa Yabe, Akira Nishimura, Koji Kato, Yoshiyuki Takahashi, Masami Inoue, Satoshi Miyamoto, Takashi Koike, Akihiro Iguchi, Kohsuke Imai, Tomonari Shigemura, Yoshiko Atsuta, Yoji Sasahara, Michiko Kajiwara, Masakatsu Yanagimachi, Motohiro Kato, Yoshiko Hashii, Mio Kurata, Masataka Ishimura, Katsutsugu Umeda
Publikováno v:
Journal of Clinical Immunology
Purpose Hematopoietic cell transplantation (HCT) is a curative therapy for patients with severe combined immunodeficiency (SCID). Here, we conducted a nationwide study to assess the outcome of SCID patients after HCT in Japan. Methods A cohort of 181
Autor:
Hideki Muramatsu, Takashi Hashimoto, Yoshiyuki Takahashi, Yoshinao Muro, Seiji Kojima, Eri Nishikawa, Atsunari Tsuchisaka, Yusuke Okuno, Nozomu Kawashima, Atsushi Narita, Motoharu Hamada, Nobuhiro Nishio, Daisuke Ichikawa
Publikováno v:
Bone Marrow Transplantation. 56:2291-2294
Autor:
Yuichi Ishikawa, Tatsunori Goto, Katsuyoshi Kato, Tetsuya Nishida, Yoshiyuki Takahashi, Sonoko Kamoshita, Seitaro Terakura, Akihiro Hirakawa, Hitoshi Kiyoi, Nobuhiro Nishio, Satoshi Nishiwaki, Yoko Ushijima, Makoto Murata, Yoshiya Adachi, Tadashi Matsushita, Yoshihisa Kodera, Satoshi Suzuki
Publikováno v:
Stem Cells Translational Medicine
Stem Cells Translational Medicine, Vol 10, Iss 4, Pp 542-553 (2021)
Stem Cells Translational Medicine, Vol 10, Iss 4, Pp 542-553 (2021)
Mesenchymal stem cells (MSCs) have immunomodulatory properties and support hematopoiesis in the bone marrow (BM). To develop a new strategy to not only prevent graft‐vs‐host disease (GVHD) but also to enhance engraftment, a phase I trial of cord
Autor:
Yoshihiro Kushida, Masahiro Tsuji, Toshihiko Suzuki, Masahiro Hayakawa, Yukako Iitani, Shigeyoshi Saito, Yoshiyuki Takahashi, Mari Dezawa, Kenji Imai, Cesar V. Borlongan, Shinobu Shimizu, Hideki Hida, Masaaki Mizuno, Takashi Temma, Shohei Wakao, Hidehiro Iida, Kazuto Ueda, Yoshiaki Sato
Publikováno v:
Journal of Cerebral Blood Flow & Metabolism
Perinatal hypoxic ischemic encephalopathy (HIE) results in serious neurological dysfunction and mortality. Clinical trials of multilineage-differentiating stress enduring cells (Muse cells) have commenced in stroke using intravenous delivery of donor
Autor:
Toshiki Nakane, Tomohiko Nakata, Yu Okai, Hisashi Kawai, Masaharu Tanaka, Hiroyuki Kidokoro, Yoko Sakaguchi, Yoshiyuki Takahashi, Toshiaki Taoka, Jun Natsume, Hiroyuki Yamamoto, Yuji Ito, Hideki Muramatsu, Atsuko Ohno, Shinji Naganawa
Publikováno v:
Pediatric Neurology. 111:78-84
Background Advances in hematopoietic stem cell transplantation have improved the survival rate of malignant diseases and congenital immunodeficiencies. It has become important to assess long-term complications in survivors. To assess neurological abn
Autor:
Masaki Yamamoto, Satoru Miyano, Hideki Muramatsu, Seishi Ogawa, Hitoshi Kanno, Yuki Yuza, Yoji Sasahara, Etsuro Ito, Seiji Kojima, Hiromasa Yabe, Nobuyuki Hyakuna, Shouichi Ohga, Daiichiro Hasegawa, Kenichi Yoshida, Masanori Nishi, Takuya Kamio, Takeo Sarashina, Harumi Kakuda, Akira Ishiguro, Yoshiyuki Takahashi, Kiminori Terui, Tomohiko Sato, Tsutomu Toki, Akie Kobayashi, Masataka Ishimura, Rika Kanezaki, Hidefumi Hiramatsu, Akira Ohara, Miyuki Tanaka, Shinya Sasaki, Ko Kudo, Shun Koyamaishi
Publikováno v:
Bone Marrow Transplantation. 56:1013-1020
Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative therapy for the hematologic manifestations of Diamond–Blackfan anemia (DBA). However, data regarding the optimal conditioning regimen for DBA patients are limited. We re
Autor:
Kuniaki Tanaka, Katsutsugu Umeda, Yoshiyuki Takahashi, Yozo Nakazawa, Miyuki Tanaka, Daisuke Morita, Junko Takita, Hidefumi Hiramatsu, Tatsutoshi Nakahata, Souichi Adachi, Itaru Kato, Kazuyuki Matsuda
Publikováno v:
Molecular Therapy: Oncolytics, Vol 18, Iss, Pp 37-46 (2020)
The anti-CD19 chimeric antigen receptor (CAR) T cells showed excellent effect against acute lymphoblastic leukemia (ALL) in bone marrow (BM) in clinical trials. However, it remains to be elucidated whether the CD19 CAR T cell therapy is effective for
Autor:
Hiroyuki Futani, Kazuhiro Kitajima, Tatsuya Tsuchitani, Koichiro Yamakado, Yoshiyuki Takahashi
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 13, Iss 2, Pp 829-834 (2020)
Case Reports in Oncology, Vol 13, Iss 2, Pp 829-834 (2020)
We here report on 2 cases of monostotic Paget’s disease of bone, one in the ilium and the other in the skull, including quantitative values obtained with bone single photon emission computed tomography/computed tomography (SPECT/CT), which were use
Autor:
Ken Tabuchi, Atsushi Ogawa, Yoshiyuki Takahashi, Atsushi Kikuta, Koji Kato, Yuhki Koga, Masami Inoue, Yoshiko Hashii, Katsuyoshi Koh, Kimikazu Matsumoto, Ryoji Kobayashi, Junichi Hara
Publikováno v:
Journal of Pediatric Hematology/Oncology. 42:251-255
Background Almost all pediatric patients with renal tumors are diagnosed with nephroblastoma (Wilms tumor), clear cell sarcoma, or malignant rhabdoid tumor. The choice of treatment is important for relapsed and refractory patients with nephroblastoma
Autor:
Tadashi Kaname, Shinji Saitoh, Naoya Yamaguchi, Kohji Kato, Ayako Hattori, Kyoko Ban, Yuji Nakamura, Atsushi Suzuki, Yusuke Okuno, Yoshiyuki Takahashi, Hideki Muramatsu
Publikováno v:
Brain and Development. 42:298-301
Mucolipidosis type IV (MLIV) is a rare lysosomal storage disorder causing severe psychomotor developmental delay and progressive visual impairment. MLIV is an autosomal recessive disease caused by mutations in MCOLN1, which encodes for mucolipin-1. H